Preeclampsia: Diagnosis and Management
Written by Dr. Muhammad Salar Raza · Manually reviewed by Dr. Muhammad Salar Raza · Content updated
Clinical Pathway
Diagnose preeclampsia with new hypertension (140/90 mmHg or higher) after 20 weeks of gestation plus proteinuria or maternal organ dysfunction. Severe features include pressure of 160/110 mmHg or higher, severe headache, visual disturbance, epigastric pain, thrombocytopenia, renal impairment, or pulmonary edema. Severe preeclampsia mandates admission, magnesium sulfate for seizure prophylaxis, and antihypertensive therapy with labetalol, oral nifedipine, or hydralazine. The definitive treatment is delivery, timed by gestational age and severity: immediate stabilization then delivery at term or with severe features, and expectant management only in carefully selected preterm cases without severe features. Continue magnesium for 24 hours postpartum.
Clinical Reasoning
Preeclampsia is diagnosed after 20 weeks; hypertension before that is chronic hypertension, and the two can coexist as superimposed preeclampsia. Proteinuria is no longer mandatory if other organ features are present, a common exam trap. Magnesium sulfate prevents eclampsia and is given for seizure prophylaxis, not for blood pressure control; monitor reflexes, respiration, and urine output, and treat toxicity with calcium gluconate. ACE inhibitors, ARBs, and direct renin inhibitors are contraindicated in pregnancy. Epigastric or right upper quadrant pain heralds hepatic involvement, and headache with hyperreflexia warns of imminent seizure.
Sample MCQ
A 28-year-old primigravida at 34 weeks has blood pressure 162/112 mmHg, severe headache, 3+ proteinuria, and hyperreflexia. The fetus is reassuring. After admission, which medication should be started first?
- AMagnesium sulfate
- BLisinopril
- COral aspirin at high dose
- DOutpatient monitoring with weekly blood pressure checks
Correct Answer: Magnesium sulfate
She has preeclampsia with severe features, and magnesium sulfate is started immediately to prevent progression to eclampsia, alongside an antihypertensive such as labetalol to control the severe pressure and planning for delivery. Lisinopril and all ACE inhibitors are contraindicated in pregnancy because of fetal renal toxicity. Low-dose aspirin is used for preeclampsia prevention starting in the first trimester in high-risk women; it has no role in acute management and high doses are harmful. Outpatient monitoring is unsafe with severe features, where seizure, stroke, and abruption risk demand inpatient stabilization and delivery planning.
Guidelines and further reading
Deep Dive Walkthroughs
Read full case walkthroughs with option-by-option analysis for this topic:
Related Clinical Topics
Chronic Hypertension: Diagnosis and Management
Chronic hypertension is a persistent and sustained elevation of blood pressure, typically defined as a systolic blood pressure greater than or equal to 130 mmHg or a diastolic blood pressure greater than or equal to 80 mmHg on multiple occasions. It is a major modifiable risk factor for various cardiovascular diseases, stroke, and kidney disease. Treatment for chronic hypertension involves a multi-faceted approach, starting with lifestyle modifications such as dietary changes (e.g., DASH diet), regular physical activity, weight loss, and reduced sodium and alcohol intake. Pharmacological therapy is often necessary and may include various classes of antihypertensive medications like diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs), beta-blockers, and calcium channel blockers, frequently used in combination to achieve target blood pressure. Chronic hypertension is often referred to as 'the silent killer' because it is frequently asymptomatic for many years, even at high levels. When symptoms do occur, they are typically non-specific and may include headaches, dizziness, nosebleeds, or shortness of breath, usually manifesting in severe or long-standing cases or during a hypertensive crisis. Most diagnoses are made during routine medical screenings.
Gestational Diabetes Mellitus (GDM): Screening and Management
Screen all pregnant women at 24-28 weeks with a 75 g oral glucose tolerance test, or earlier when risk factors such as obesity or previous GDM exist. First-line management is medical nutrition therapy with structured physical activity and daily glucose self-monitoring. If fasting or postprandial targets are repeatedly exceeded despite lifestyle measures, start insulin, with metformin as an accepted alternative in many guidelines. Monitor fetal growth because GDM drives macrosomia, and plan delivery around 38-39 weeks when medication is required. After delivery, insulin needs fall sharply; arrange a 75 g OGTT at 6-12 weeks postpartum because about half of women with GDM later develop type 2 diabetes.
Maternal Physiological Adaptations in Pregnancy
During a normal singleton pregnancy, the maternal circulatory system undergoes remarkable physiological adaptations to support the developing fetus, meet increased metabolic demands, and prepare for the demands of labor and delivery. These changes are initiated early in gestation and progress throughout pregnancy, typically peaking by 32-34 weeks. One of the most critical and prominent adaptations is a significant expansion of the total maternal blood volume. Plasma volume increases disproportionately, typically by 40-50% above non-pregnant levels. Red blood cell mass also increases, but to a lesser extent, usually by 20-30% (more with adequate iron supplementation). The combined effect results in an overall increase in total blood volume by approximately 40-45% by term.
SMLE Preparation Resources
Master the 2026 SMLE
Explore more clinical protocols in the SMLEREVISE Clinical Knowledge Library.
Try the QBank & Scaled Mocks